MMC and VICC: Partners in Eliminating Cancer Disparities

MMC 和 VICC：消除癌症差异的合作伙伴

• 批准号: 7490635
• 负责人: Samuel Evans Adunyah
• 金额: $ 171.08万
• 依托单位: MEHARRY MEDICAL COLLEGE
• 依托单位国家: 美国
• 财政年份: 2001
• 资助国家: 美国
• 起止时间: 2001-08-03 至 2011-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7490635
• 关键词: MMC; VICC; Partners; Eliminating; Cancer

The overall objectives of this competing continuation application are to strengthen and expand the existing partnership for cancer research between Meharry Medical College (MMC) and the Vanderbilt Ingram Cancer Center (VICC) to achieve three ends: (1) to increase and stabilize the competitive cancer research capability of MMC; (2) to create stable, long term collaborative relationships between MMC and the VICC in cancer research, research training and career development; (3) to promote, enable and cement a stable, reciprocal, long-term partnership between MMC and VICC based on mutually beneficial research excellence. This partnership is one of very few U54s with a balanced focus on population sciences, basic and clinical research. In this application we seek to expand MMC's competitive cancer research capability by means of one full research project, three pilot projects, and two pre-pilots. All seven projects involve collaborators at VICC, thus strengthening the relationship that VICC and MMC have established during the first funding period. In addition, we seek to establish new core resources for tissue acquisition, biostatistics and community outreach, and to continue a clinical trials core that enables MMC to participate in national oncology trials.. We plan also to recruit new faculty investigators in basic science, medical oncology, and epidemiology, and to expand our existing research training program for doctoral students by adding a fellow in medical oncology. All of these activities involve coordinated, well-planned interaction between MMC and VICC and will be monitored by an internal advisory committee composed of members from both schools, and a Program Steering Committee composed of nationally-recognized cancer investigators from other institutions. The proposed project will move the Meharry-Vanderbilt Cancer Partnership toward a fully reciprocal relationship characterized by shared pursuit of excellence and full sharing of each others' strengths.

此竞争连续申请的总体目标是加强和扩展现有的 Meharry医学院（MMC）和Vanderbilt Ingram癌症之间的癌症研究合作伙伴关系 中心（VICC）达到三端：（1）增加和稳定竞争性癌症研究能力 MMC; （2）在癌症中建立MMC与VICC之间的稳定，长期的协作关系 研究，研究培训和职业发展； （3）促进，启用和巩固稳定的，相互的 MMC与VICC之间的长期合作关系基于互惠研究的卓越。这 合作伙伴关系是极少数的U54之一，专注于人群科学，基础和临床科学 研究。 在此应用中，我们试图通过一个完整的方式扩展MMC的竞争性癌症研究能力 研究项目，三个试点项目和两个前射手。所有七个项目都涉及VICC的合作者 从而加强了VICC和MMC在第一个资金期间建立的关系。在 此外，我们试图为组织获取，生物统计学和社区建立新的核心资源 外展，并继续一个临床试验核心，使MMC能够参加国家肿瘤学试验。 我们还计划招募基础科学，医学肿瘤学和流行病学的新教师调查员，以及 通过添加医学研究员来扩大我们为博士生的现有研究培训计划 肿瘤学。所有这些活动都涉及MMC和VICC之间的协调，计划完好的相互作用 将由由两所学校的成员组成的内部咨询委员会监控， 计划指导委员会由来自其他机构的全国认可的癌症调查员组成。 拟议的项目将将Meharry-Vanderbilt癌症伙伴关系转移到完全倒数 关系的特征是共同追求卓越和彼此的优势完全分享。